J. T. Kemshead

3.1k total citations · 1 hit paper
72 papers, 2.4k citations indexed

About

J. T. Kemshead is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J. T. Kemshead has authored 72 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Neurology, 33 papers in Radiology, Nuclear Medicine and Imaging and 21 papers in Molecular Biology. Recurrent topics in J. T. Kemshead's work include Neuroblastoma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (23 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). J. T. Kemshead is often cited by papers focused on Neuroblastoma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (23 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). J. T. Kemshead collaborates with scholars based in United Kingdom, India and United States. J. T. Kemshead's co-authors include Melvyn F. Greaves, Robert Sutherland, C. Schneider, Roland Newman, D Delia, Hugh B. Coakham, Jeremy A. Garson, K. Patel, Patricia Allan and Betty Brownell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

J. T. Kemshead

69 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

1981 599 citations J. T. Kemshead et al. profile →

Peers

Countries citing papers authored by J. T. Kemshead

Since Specialization

Citations

This map shows the geographic impact of J. T. Kemshead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. T. Kemshead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. T. Kemshead more than expected).

Fields of papers citing papers by J. T. Kemshead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. T. Kemshead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. T. Kemshead. The network helps show where J. T. Kemshead may publish in the future.

Co-authorship network of co-authors of J. T. Kemshead

This figure shows the co-authorship network connecting the top 25 collaborators of J. T. Kemshead. A scholar is included among the top collaborators of J. T. Kemshead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. T. Kemshead. J. T. Kemshead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The detection of tyrosinase mRNA in peripheral blood samples is unlikely to aid in the management of patients with localised malignant melanoma 2003 ·British Journal of Plastic Surgery ·Robert Warr, (unknown), John Kenealy, H Rigby, J. T. Kemshead	6
2	Detection of melanoma seeding during surgical procedures – an RT-PCR based model 2002 ·European Journal of Surgical Oncology ·Robert Warr, (unknown), John Kenealy, H Rigby, J. T. Kemshead	4
3	Treatment of Diffuse Leptomeningeal Malignancy by Intrathecal Injection of 131I Radioimmunoconjugates 1996 ·Recent results in cancer research ·J. T. Kemshead, (unknown), C Chandler	6
4	The Treatment of Patients with Recurrent Malignant Gliomas with Intratumoral Radioimmunoconjugates 1996 ·Recent results in cancer research ·Kirsten Hopkins, (unknown), J. T. Kemshead	12
5	Vase mini‐exon usage by ncam is not restricted to tumours of neuroectodermal origin 1993 ·International Journal of Cancer ·K. Patel, (unknown), (unknown), J. T. Kemshead, Elizabeth G. Phimister	5
6	A rapid and highly selective approach to cell separations using an immunomagnetic colloid 1993 ·Journal of Immunological Methods ·Jeremy Hancock, J. T. Kemshead	48
7	Neuroblastoma in the very young child: biological considerations. 1992 ·PubMed ·J. T. Kemshead, K. Patel, (unknown)	5
8	Splicing of the vase exon of neural cell adhesion molecule (NCAM) in human small‐cell lung carcinoma (SCLC) 1992 ·International Journal of Cancer ·Hans L. P. van Duijnhoven, Wijnand Helfrich, Lou de Leij, Anton Roebroek, Wim J.M. Van de Ven, Kelley R. Healey, (unknown), (unknown), J. T. Kemshead, K. Patel	5
9	A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm 1991 ·Journal of Neuro-Oncology ·Stephen P. Bourne, K. Patel, F S Walsh, (unknown), Hugh B. Coakham, J. T. Kemshead	49
10	Expression of alternative isoforms of the neural cell adhesion molecule (NCAM) on normal brain and a variety of brain tumours 1991 ·Neuropathology and Applied Neurobiology ·Gary Frost, K. Patel, Stephen P. Bourne, Hugh B. Coakham, J. T. Kemshead	17
11	Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C) 1991 ·International Journal of Cancer ·L. S. Lashford, Jeremy Hancock, J. T. Kemshead	42
12	Bone marrow examination in neuroblastoma patients: A morphologic, immunocytochemical, and immunohistochemical study 1989 ·Human Pathology ·B.R. Oppedal, Ingebjørg Storm‐Mathisen, J. T. Kemshead, P Brandtzæg	15
13	Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma 1989 ·International Journal of Cancer ·K. Patel, Sophie E. Moore, George Dickson, (unknown), Peter C. L. Beverley, J. T. Kemshead, F S Walsh	114
14	Neoplastic Meningitis from a Pineal Tumour Treated by Antibody-guided Irradiation via the Intrathecal Route 1988 ·British Journal of Neurosurgery ·H.B. Coakham, Richard B. Richardson, Alun Davies, Stephen P. Bourne, (unknown), J. T. Kemshead	20
15	Diagnosis and Therapy of Neuroectodermally Associated Tumours Using Targeted Radiation 1987 ·Developmental Neuroscience ·J. T. Kemshead, L. S. Lashford, (unknown), Hugh B. Coakham	8
16	High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma 1987 ·Cytogenetic and Genome Research ·Jeremy A. Garson, (unknown), J. T. Kemshead	18
17	Immunohistochemical differentiation of neuroblastomas from other small round cell neoplasms of childhood using a panel of mono‐and polyclonal antibodies 1987 ·Histopathology ·B.R. Oppedal, P Brandtzæg, J. T. Kemshead	18
18	Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model 1987 ·Journal of Neuroimmunology ·Carol J. Wikstrand, Roger E. McLendon, S Carrel, J. T. Kemshead, J.-P. Mach, Hugh B. Coakham, Nicolas de Tribolet, Dennis E. Bullard, Michael R. Zalutsky, Darell D. Bigner	30
19	Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. 1986 ·PubMed ·Tohru Sugimoto, T. Sawada, Takafumi Matsumura, J. T. Kemshead, (unknown), Yoshihiro Horii, Hiroyuki Morioka, Masao Morita, C. Patrick Reynolds	32
20	131-I Coupled to Monoclonal Antibodies as Therapeutic Agents for Neuroectodermally Derived Tumors: Fact or Fiction? 1986 ·PubMed ·J. T. Kemshead, (unknown), L. S. Lashford, Jeffrey W. Prichard, I. Gordon, Fin Breatnach, H.B. Coakham	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact